Frequent overexpression of the cyclin D1 oncogene in invasive lobular carcinoma of the breast

Cancer Research

Volumn 58, Issue 13, 1998, Pages 2876-2880

  Oyama, Tetsunari ^a,b   Kashiwabara, Kenji ^b   Yoshimoto, Katsuhiko ^a,c   Arnold, Andrew ^a,c   Koerner, Frederick ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b GUNMA UNIVERSITY   (Japan)

^c UNIVERSITY OF CONNECTICUT SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN D1;

ARTICLE; BREAST CANCER; CANCER GRADING; CANCER GROWTH; CELL CYCLE; CYTODIAGNOSIS; GENE AMPLIFICATION; GENE OVEREXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; INVASIVE CARCINOMA; PRIORITY JOURNAL; SOUTHERN BLOTTING;

BREAST NEOPLASMS; CARCINOMA, LOBULAR; CELL CYCLE PROTEINS; CYCLIN D1; CYCLIN-DEPENDENT KINASE INHIBITOR P27; DISEASE PROGRESSION; FEMALE; HUMANS; KI-67 ANTIGEN; MICROTUBULE-ASSOCIATED PROTEINS; NEOPLASM PROTEINS; RECEPTORS, ESTROGEN; TUMOR SUPPRESSOR PROTEINS;

EID: 0032126542     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (53)

1. 1 phase progression: cycling on cue. Cell, 79: 551-555, 1994.
2. 1. Genes Dev., 7: 812-821, 1993.
3. Weinberg, R. A. The retinoblastoma protein and cell cycle control. Cell, 81: 323-330, 1995.
4. Lukas, J., Parry, D., Aagaard, L., Mann, D. J., Bartkova, J., Strauss, M., Peters, G., and Bartek, J. Retinoblastoma-protein-dependent cell-cycle inhibition by the tumour suppressor p16. Nature (Lond.), 375: 503-506, 1995.
5. 1 cyclin-dependent kinases. Genes Dev., 9: 1149-1163, 1995.
6. Arnold, A. The cyclin D1/PRAD1 oncogene in human neoplasia. J. Invest. Med., 43: 543-549, 1995.
7. Yang, W-I., Zukerberg, L. R., Motokura, T., Arnold, A., and Harris, N. L. Cyclin D1 (Bcl-1, PRAD1) protein expression in low-grade B-cell lymphomas and reactive hyperplasia. Am. J. Pathol., 145: 86-96, 1994.
8. Williams, M. E., Swerdlow, S. H., Rosenberg, C. L., and Arnold, A. Chromosome 11 translocation breakpoints at the PRAD1/cyclin D1 gene locus in centrocytic lymphoma. Leukemia (Baltimore), 7: 241-245, 1993.
9. Arnold, A., Kim, H. G., Gaz, R. D., Eddy, R. L., Fukushima, Y., Byers, M. G., Shows, T. B., and Kronenberg, H. M. Molecular cloning and chromosomal mapping of the DNA rearranged with the parathyroid hormone gene in a parathyroid adenoma. J. Clin. Invest., 83: 2034-2040, 1989.
10. Motokura, T., Bloom, T., Kim, H. G., Juppner, H., Ruderman, J. V., Kronenberg, H. M., and Arnold, A. A novel cyclin encoded by a bcb1-linked candidate oncogene. Nature (Lond.), 350: 512-515, 1991.
11. Gillett, C., Fantl, V., Smith, R., Fisher, C., Bartek, J., Dickson, C., Barnes, D., and Peters, G. Amplification and overexpression of cyclin D1 in breast cancer detected by immunohistochemical staining. Cancer Res., 54: 1812-1817, 1994.
12. Lammie, G. A., Fantl, V., Smith, R., Schuuring, E., Brookes, S., Michalides, R., Dickson, C., Arnold, A., and Peters, G. D11S287, a putative oncogene on chromosome 11q13, is amplified and expressed in squamous cell and mammary carcinomas and linked to BCL-1. Oncogene, 6: 439-444, 1991.
13. Worsley, S. D., Jennings, B. A., Khalil, K. H., and Girling, A. C. Cyclin D1 amplification and expression in human breast carcinoma: correlation with histological prognostic markers and oestrogen receptor expression. J. Clin. Pathol.: Mol. Pathol., 49: M46-M50, 1996.
14. Theillet, C., Adane, J., Szepetowski, P., Simon, M-P., Jeanteur, P., Birnbaum, D., and Gaudray, P. BCL-1 participates in the 11q13 amplification found in breast cancer. Oncogene, 5: 147-149, 1990.
15. Borg, A., Sigurdsson, H., Clark, G. M., Ferno, M., Fuqua, S. A. W., Olsson, H., Killander, D., and McGuire, W. L. Association of the INT2/HST1 coamplification in primary breast cancer with hormone-dependent phenotype and poor prognosis. Br. J. Cancer, 63: 136-142, 1991.
16. Fantl, V., Richards, M. A., Smith, R., Lammie, G. A., Johnstone, G., Allen, D., Gregory, W., Peters, G., Dickson, C., and Barnes, D. M. Gene amplification on chromosome band 11q13 and oestrogen receptor status in breast cancer. Eur. J. Cancer, 26: 423-429, 1990.
17. Ali, I. U., Merlo, G., Callahan, R., and Lidereau, R. The amplification unit on chromosome 11q13 in aggressive primary human breast tumors entails the bcl-1, int-2 and hst loci. Oncogene, 4: 89-92, 1989.
18. Adnane, J., Gaudray, P., Simon, M-P., Simony-Lafontaine, J., Jeanteur, P., and Theillet, C. Proto-oncogene amplification and human breast tumor phenotype. Oncogene, 4: 1389-1395, 1989.
19. Zhou, D-J., Ahuja, H., and Cline, M. J. Proto-oncogene abnormalities in human breast cancer: c-ERBB-2 amplification does not correlate with recurrence of disease. Oncogene, 4: 105-108, 1989.
20. Zhang, S-Y., Caamano, J., Cooper, F., Guo, X., and Klein-Szanto, A. J. P. Immunohistochemistry of cyclin D1 in human breast cancer. Am. J. Clin. Pathol., 102: 695-698, 1994.
21. Frierson, H. F., Gaffey, M. J., Zukerberg, L. R., Arnold, A., and Williams, M. E. Immunohistochemical detection and gene amplification of cyclin D1 in mammary infiltrating ductal carcinoma. Mod. Pathol., 9: 725-730, 1996.
22. Wang, T. C., Cardiff, R. D., Zukerberg, L., Lees, E., Arnold, A., and Schmidt, E. V. Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice. Nature (Lond.), 369: 669-671, 1994.
23. Arber, N., Doki, Y., Han, E. K., Sgambato, A., Zhou, P., Kim, N, H., Delohery, T., Klein, M. G., Holt, P. R., and Weinstein, I. B. Antisense to cyclin D1 inhibits the growth and tumorigenicity of human colon cancer cells. Cancer Res., 57: 1569-1574, 1997.
24. Zukerberg, L. R., Yang, W-I., Gadd, M., Thor, A. D., Koerner, F. C., Schmidt, E. V., and Arnold, A. Cyclin D1 (PRAD1) protein expression in breast cancer: approximately one-third of infiltrating mammary carcinomas show overexpression of the cyclin D1 oncogene. Mod. Pathol., 8: 560-567, 1995.
25. Bartkova, J., Lukas, J., Muller, H., Lutzhoft, D., Strauss, M., and Bartek, J. Cyclin D1 protein expression and function in human breast cancer. Int. J. Cancer, 57: 353-361, 1994.
26. Michalides, R., Hageman, P., van Tinteren, H., Houben, L., Wientjens, E., Klompmaker, R., and Peterse, J. A clinicopathological study on overexpression of cyclin D1 and of p53 in a series of 248 patients with operable breast cancer. Br. J. Cancer, 73: 728-734, 1996.
27. Jares, P., Rey, M. J., Femandez, P. L., Campo, E., Nadal, A., Muñoz, M., Mallofre, C., Mutane, J., Nayach, I., Estape, J., and Cardesa, A. Cyclin D1 and retinoblastoma gene expression in human breast carcinoma: correlation with tumor proliferation and oestrogen receptor status. J. Pathol., 182: 160-166, 1997.
28. van Diest, P. J., Michalides, R. J. A. M., Jannink, I., van der Valk, P., Peterse, H. L., de Jong, J. S., Meijer, C. J. L. M., and Baak, J. P. A. Cyclin D1 expression in invasive breast cancer. Correlations and prognostic value. Am. J. Pathol., 150: 705-711, 1997.
29. McIntosh, G. G., Anderson, J. J., Milton, I., Steward, M., Parr, A. H., Thomas, M. D., Henry, J. A., Angus, B., Lennard, T. W. J., and Home, C. H. W. Determination of the prognostic value of cyclin D1 overexpression in breast cancer. Oncogene, 11: 885-891, 1995.
30. Weinstat-Saslow, D., Merino, M. J., Manrow, R. E., Lawrence, J. A., Bluth, R. F., Wittenbel, K. D., Simpson, J. F., Page, D. L., and Steeg, P. S. Overexpression of cyclin D mRNA distinguishes invasive and in situ breast carcinomas from non-malignant lesions. Nat. Med., 1: 1257-1260, 1995.
31. Sicinski, P., Donaher, J. L., Parker, S. B., Li, T., Fazeli, A., Gardner, H., Haslam, S. Z., Bronson, R. T., Elledge, S. J., and Weinberg, R. A. Cyclin D1 provides a link between development and oncogenesis in the retina and breast. Cell, 82: 621-630, 1995.
32. Fantl, V., Stamp, G., Andrews, A., Rosewell, I., and Dickson, C. Mice lacking cyclin D1 are small and show defects in eye and mammary gland development. Genes Dev., 9: 2364-2372, 1995.
33. Nakamura, S., Seto, M., Banno, S., Suzuki, S., Koshikawa, T., Kitoh, K., Kagami, Y., Ogura, M., Yatabe, Y., Kojima, M., Motoori, T., Takahashi, T., Ueda, R., and Suchi, T. Immunohistochemical analysis of cyclin D1 protein in hematopoietic neoplasms with special reference to mantle cell lymphoma. Jpn. J. Cancer Res., 85: 1270-1279, 1994.
34. Kuroda, H., Komatsu, H., Nakamura, S., Niitsu, Y., Takahashi, T., Ueda, R., and Seto, M. The positive nuclear staining observed with monoclonal antibody against PRAD1/cyclin D1 correlates with mRNA expression in mantle cell lymphoma. Jpn. J. Cancer Res., 86: 890-898, 1995.
35. Kip1 protein: prognostic implications in primary breast cancer. Nat. Med., 2: 227-230, 1997.
36. Hosokawa, Y., and Arnold, A. Mechanisms of cyclin D1 (CCND1, PRAD1) overexpression in human cancer cells: analysis of allele-specific expression. Genes Chromosomes Cancer, 22: 66-71, 1998.
37. KIP1 protein in human esophageal cancer cell lines that overexpress cyclin D1. Carcinogenesis (Lond.), 18: 1139-1148, 1997.
38. Cedes, J., Lemke, H., Baisch, H., Wacker, H., Schwab, U., and Stein, H. Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67. J. Immunol., 133: 1710-1715, 1984.
39. Rb phosphorylation during mitogenic stimulation of G-arrested human breast cancer cells. Oncogene, 12: 2315-2324, 1996.
40. Foster, J. S., and Wimalasena, J. Estrogen regulates activity of cyclin-dependent kinases and retinoblastoma protein phosphorylation in breast cancer cells. Mol. Endocrinol., 10: 488-498, 1996.
41. 1-S phase progression is accompanied by increased cyclin D1 expression and decreased cyclin-dependent kinase inhibitor association with cyclin E-cdk2. J. Biol. Chem., 272: 10882-10894, 1997.
42. Zhu, X., Ohtsubo, M., Bohmer, R. M., Roberts, J. M., and Assoian, R. K. Adhesion-dependent cell cycle progression linked to the expression of cyclin D1, activation of cyclin E-cdk2, and phosphorylation of the retinoblastoma protein. J. Cell Biol., 133: 391-403, 1996.
43. Radeva, G., Petrocelli, T., Behrend, E., Leung-Hagesteijn, C., Filmus, J., Slingerland, J., and Dedhar, S. Overexpression of the integrin-linked kinase promotes anchorage-independent cell cycle progression. J. Biol. Chem., 272: 13937-13944, 1997.
44. Koukoulis, G. K., Virtanen, I., Korhonen, M., Laitinen, L., Quaranta, V., and Gould, V. E. Immunohistochemical localization of integrins in the normal, hyperplastic, and neoplastic breast. Correlations with their functions as receptor and cell adhesion molecules. Am. J. Pathol., 139: 787-799, 1991.
45. Pignatelli, M., Cardillo, M. R., Hanby, A., and Stamp, G. W. H. Integrins and their accessory adhesion molecules in mammary carcinoma: loss of polarization in poorly differentiated tumors. Hum. Pathol., 23: 1159-1166, 1992.
46. Zukerberg, L. R., Benedict, W. F., Arnold, A., Dyson, N., Harlow, E., and Harris, N. L. Expression of the retinoblastoma protein in low-grade B-cell lymphoma: relationship to cyclin D1. Blood, 88: 268-276, 1996.
47. Zwijsen, R. M. L., Wientjens, E., Klompmaker, R., van der Sman, J., Bernards, R., and Michalides, R. J. A. M. CDK-independent activation of estrogen receptor by cyclin D1. Cell, 88: 405-415, 1997.
48. Neuman, E., Ladha, M. H., Lin, N., Upton, T. M., Miller, S. J., DiRenzo, J., Pestell, R. G., Hinds, P. W., Dowdy, S. F., Brown, M., and Ewen, M. E. Cyclin D1 stimulation of estrogen receptor transcriptional activity independent of cdk4. Mol. Cell. Biol., 17: 5338-5347, 1997.
49. Thompson, E. W., Reich, R., Shima, T. B., Albini, A., Graf, J., Martin, G. R., Dickson, R. B., and Lippman, M. F. Differential regulation of growth and invasiveness of MCF-7 breast cancer cells by antiestrogens. Cancer Res., 48: 6764-6768, 1988.
50. Sastre-Garau, X., Jouve, M., Asselain, B., Vincent-Salamon, A., Beuzeboc, P., Dorval, T., Durand, J-C., Fourquet, A., and Pouillart, P. Infiltrating lobular carcinoma of the breast. Clinicopathologic analysis of 975 cases with references to data on conservative therapy and metastatic patterns. Cancer (Phila.), 77: 113-120, 1996.
51. Zhou, P., Jiang, W., Weghorst, C. M., and Weinstein, I. B. Overexpression of cyclin D1 enhances gene amplification. Cancer Res., 56: 36-39, 1996.
52. Lahti, J. M., Li, H., and Kidd, V. J. Elimination of cyclin D1 in vertebrate cells leads to an altered cell cycle phenotype, which is rescued by Overexpression of murine cyclins D1, D2, or D3 but not by a mutant cyclin D1. J. Biol. Chem., 272: 10859-10869, 1997.
53. kip1, inhibits growth, and enhances apoptosis. Cell Growth Differ., 7: 699-710, 1996.